Skip to main content
17/04/2007 - 22:00

pSivida sells subsidiary for $3.6m

17/04/2007 - 22:00

Bookmark

Save articles for future reference.

PERTH-HEADQUARTERED bio-nanotech company, pSivida Ltd, has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company’s planned float on the Frankfurt Stock Exchange.

X

To read our articles you will need to either login or subscribe.